eli-lilly:-gewichtverlust-offensive-und-neue-kooperationen - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,839 +0.83%

DJIA 48,339 +0.90%

Nasdaq 25,091 +0.79%

DAX 23,928 -0.15%

Gold $4,196 +0.16%

Oil $95.75 -0.97%

BTC $72,426 +1.48%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

S&P 500 6,839 +0.83%

DJIA 48,339 +0.90%

Nasdaq 25,091 +0.79%

DAX 23,928 -0.15%

Gold $4,196 +0.16%

Oil $95.75 -0.97%

BTC $72,426 +1.48%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

eli-lilly:-gewichtverlust-offensive-und-neue-kooperationen

Eli Lilly Weight-Loss Strategy illustrated by GLP-1 drug research lab with injectables and oral pills

Pharma & Healthcare·Stocks·USA

Eli Lilly Weight-Loss Strategy vs Novo: Price War Shock

By Maik Kemper • Apr 7, 2026

Eli Lilly Weight-Loss Strategy illustrated by GLP-1 drug research lab with injectables and oral pills

Pharma & Healthcare·Stocks·USA

Eli Lilly Weight-Loss Strategy vs Novo: Price War Shock

By Maik Kemper • Apr 7, 2026

Can the Eli Lilly Weight-Loss Strategy stay on top as Novo Nordisk slashes prices and AI reshapes the obesity drug race? Maik Kemper Editor in…